Matrixyl Peptides 10mg 10vials 1kits

Description

High purity Matrixyl Research Peptide | Palmitoylated Messenger Peptides (Matrikines)

Product Profile

Matrixyl peptides represent a premier class of synthetic, fatty-acid-conjugated messenger signaling molecules (matrikines) engineered to regulate extracellular matrix (ECM) structural components. [Matrixyl peptides stimulate dermal fibroblasts]. This highly pure peptide family??encompassing original Matrixyl (Palmitoyl Pentapeptide-4) and Matrixyl 3000 (Palmitoyl Tripeptide-1 and Palmitoyl Tetrapeptide-7)??serves as an absolute research benchmark for investigating de novo collagen synthesis, elastic fiber alignment, and the reversal of photo-induced dermal senescence.

Specification Sheet

• Active Variants: Palmitoyl Pentapeptide-4 (Matrixyl), Palmitoyl Tripeptide-1 / Palmitoyl Tetrapeptide-7 Blend (Matrixyl 3000)
• CAS Numbers: 214047-00-4 (Pal-KTTKS) / 147732-56-7 & 221227-05-0 (Matrixyl 3000)
• Purity: >99.0% via HPLC-UV
• Appearance: Sterile white lyophilized powder cake

Pharmacodynamics

The biochemical activity of Matrixyl is defined by its ability to act as a localized feedback signal that mimics natural ECM breakdown fragments, thereby tricking target cells into upregulating structural synthesis. Initially, the attached lipophilic palmitoyl chain allows the peptide to cross standard hydrophobic cellular boundaries efficiently. This defines the first semantic triple: [Palmitoyl conjugation enhances lipid permeability]. Following this, the liberated peptide core docks onto specific transmembrane receptors on dermal fibroblasts. This establishes the second triple: [Matrikines activate fibroblast surface receptors]. Thirdly, this receptor engagement triggers downstream intracellular signaling cascades that turn on the genetic transcription of structural scaffolding. This forms the third triple: [Fibroblast activation upregulates type I collagen synthesis]. Quantitatively, the palmitoylated structure significantly extends the localized tissue half-life to approximately 4 to 6 hours ($t_{1/2}=5.0pm1.0$h) compared to native, un-conjugated peptide fragments. In comparative studies, Matrixyl is distinguished from GHK-Cu; while GHK-Cu acts as a copper chaperone utilizing coordinate bonds to drive broad-spectrum tissue remodeling and macro-wound healing, Matrixyl operates purely as a targeted chemical messenger that directly increases specific collagen, elastin, and glycosaminoglycan synthesis via classical ligand-receptor cascades.

Experimental Outcomes

• Profound Collagen Synthesis: Users in research models report a rapid and sustained increase in dermal density and structural scaffolding thickness.
• Rhytid Volume Reduction: Study data demonstrates a significant flattening and shortening of deep expression lines and micro-wrinkles over extended testing windows.
• Optimized Extracellular Hydration: Per experimental records, research models show vastly augmented hyaluronic acid production, resulting in elevated dermal turgor.
• Attenuated Inflammatory Signaling: In Matrixyl 3000 models, the palmitoyl tetrapeptide-7 fraction demonstrates a marked suppression of interleukin-6 (IL-6), protecting the skin from premature glycation and enzymatic destruction.
• Enhanced Skin Elasticity: Cumulative findings indicate a measurable return of mechanical recoil and rebound resilience within fragile skin matrices.

Key Points:
Matrixyl peptides represent an absolute gold-standard research tool for investigating targeted matrikine-driven fibroblast activation and the molecular pathways of structural matrix rejuvenation.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.